Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
55.50    0.50 (0.91%)
Bid:
54.00
Ask:
57.00
Spread: 3.00 (5.556%)
Market Cap: £106.48m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

Atlantis Water Project Update

29 Apr 2013 07:00

RNS Number : 4262D
Iofina PLC
29 April 2013
 



 

 

29 April 2013

 

 

Iofina plc

("Iofina" or the "Company")

(LSE AIM: IOF)

 

Atlantis Water Project Update

 

Iofina, a specialist in the exploration and production of iodine and specialty chemical iodine derivatives,

is pleased to provide the following update in respect of its Atlantis Water Project.

Based on initial responses from and discussions with the Montana Department of Natural Resource Conservation ("DNRC") Water Resources Office following their receipt of the Company's water right permit application, the Company has elected to amend its water permit application in an effort to expedite its plan to market 10,000 acre-feet per year (c.200,000 barrels per day) of freshwater in eastern Montana.

The possibility of needing to amend the original application was anticipated and envisioned as part of this process and the Company has decided to amend its application to expedite the application process. The Company's revised application is to develop a water depot for 3,800 acre-feet per year based on customers' needs at the current planned location. The Company has secured strategic locations for the first water pumping station and place of sale for its initial terminal and recently submitted an amended application to reflect this. The Company is actively acquiring additional strategically placed sites, based on demand and ease of transportation, for two additional depots that, together with the initial depot, will total over 10,000 acre-feet per year as planned.

After discussing the status of the application with the central Water Resources Office, the Company was informed that the department removed the original application from its website, but has not terminated the original application. The original application remains valid pending receipt of the amended application.

 

About Iofina

Iofina specialises in the exploration and production of iodine, iodine specialty chemical derivatives, produced water and natural gas. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb™ technology. Iofina has iodine production operations in the United States, specifically in Texas, California, Montana, Oklahoma and Wyoming. The Group has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes in Europe, North America and Asia. The Group utilises its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.  

 

For further information, please contact:

 

Stuart Eaton, Executive Operations Officer

Iofina plc

Tel: +44(0)7500 042 516

www.iofina.com

 

Dr Chris Fay, Executive Chairman

Iofina plc

Tel: +44(0)7747 693 486

Ben Colegrave/Chris Sim/Neil Elliot

Investec

Tel: +44(0)20 7597 5970

 

Media Contact:

Dominic Barretto/Anna Legge

Yellow Jersey PR Limited

Tel: +44(0) 7768 537 739 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEANLPASNDEFF
Date   Source Headline
24th May 20174:40 pmRNSSecond Price Monitoring Extn
24th May 20174:35 pmRNSPrice Monitoring Extension
24th May 201712:07 pmRNSSecond Price Monitoring Extn
24th May 201712:02 pmRNSPrice Monitoring Extension
19th May 20177:00 amRNSFinal Results and Notice of AGM
3rd May 20174:41 pmRNSSecond Price Monitoring Extn
3rd May 20174:35 pmRNSPrice Monitoring Extension
25th Apr 20174:40 pmRNSSecond Price Monitoring Extn
25th Apr 20174:35 pmRNSPrice Monitoring Extension
11th Apr 20177:00 amRNSTrading Update
3rd Apr 20177:00 amRNSProduction update
14th Feb 20174:35 pmRNSPrice Monitoring Extension
13th Jan 20177:00 amRNSCorporate Update
13th Dec 20164:35 pmRNSPrice Monitoring Extension
12th Dec 20167:00 amRNSCorporate update
2nd Dec 20167:00 amRNSChange of Registered Office
4th Nov 20167:00 amRNSDirectorate Change
13th Oct 20167:00 amRNSTrading Update
30th Sep 20167:00 amRNSCompletion of Debt Restructure
30th Sep 20167:00 amRNSInterim Results
12th Sep 20164:35 pmRNSPrice Monitoring Extension
17th Aug 20164:40 pmRNSSecond Price Monitoring Extn
17th Aug 20164:35 pmRNSPrice Monitoring Extension
11th Aug 20161:33 pmRNSWater Depot Permit Update
25th Jul 20164:40 pmRNSSecond Price Monitoring Extn
25th Jul 20164:35 pmRNSPrice Monitoring Extension
11th Jul 20167:00 amRNSCorporate and Production Update
7th Jun 201611:37 amRNSResult of AGM
7th Jun 20167:00 amRNSRestructure of Debt
9th May 20167:00 amRNSFinal Results and Notice of AGM
11th Apr 20167:00 amRNSMarket update
15th Feb 20167:00 amRNSDirectorate Change
18th Jan 20167:00 amRNSCorporate Update
14th Dec 20157:00 amRNSTrading Update
23rd Nov 20157:00 amRNSBrine Supply Update
28th Oct 20157:00 amRNSAppointment of CFO
15th Oct 20159:00 amRNSIofina becomes founding member of the WIA
9th Oct 20157:00 amRNSProduction and Corporate Update
5th Oct 20151:59 pmRNSChange of Registered Office
29th Sep 20157:00 amRNSInterim Results
14th Jul 20157:00 amRNSCorporate & Trading Update
22nd Jun 20155:41 pmRNSHolding(s) in Company
19th Jun 201512:05 pmRNSResult of AGM
16th Jun 20157:00 amRNSProduction Update
5th Jun 20157:00 amRNSWater Depot Permit Update
27th May 20157:00 amRNSFinal Results and Notice of AGM
11th May 20157:00 amRNSAnnouncement of Final Results
22nd Apr 20157:00 amRNSChange of Adviser
15th Apr 20157:00 amRNSProduction Update & Notice of Results
13th Jan 20157:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.